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Abstract.  The focal adhesion protein paxillin  under- 
goes tyrosine phosphorylation  in response to signals 
mediated by integrins,  neuropeptides  and oncogene 
products,  possibly via activation  of the focal adhesion- 
associated kinase,  p125 FAz. In the present  work,  tumor 
necrosis  factor-or (TNF)  stimulated  tyrosine phos- 
phorylation  of paxillin  in human  neutrophils.  Cell 
adhesion  and participation  of the/~2  integrin  CD18 
were necessary, but not sufficient,  for the response.  Ad- 
herent  neutrophils  also tyrosine phosphorylated paxil- 
lin in response to phorbol ester,  formylmethionyl- 
leucyl-phenylalanine  and opsonized bacteria.  In 
contrast,  p125 FAK was constitutively tyrosine phos- 
phorylated  in a  manner  unaffected by adherence and/or 
TNE  Thus,  cytokines and microbial products are 
among the stimuli that can induce the tyrosine phos- 
phorylation  of paxillin,  and kinases other than  p125 FAz 
may be responsible.  This  is the first identification  of 
paxillin  and p125 FAK in human cells and neutrophils, 
and one of the few identifications  of a  specific protein 
that undergoes tyrosine phosphorylation  in response to 
any agonist in neutrophils  or in response to TNF in 
any cell. 
S 
URVIVAL of mammals  depends on the ability of neu- 
trophilic  polymorphonuclear  leukocytes  (PMN) t  to 
adhere to endothelium,  emigrate into infected tissue, 
form abscesses, and kill bacteria.  Key aspects of these re- 
sponses  are  modeled by plating  PMN on matrix  protein- 
coated surfaces and stimulating the secretion of oxidants and 
proteases  with  inflammatory  polypeptides  (18, 21,  22). 
Among effective stimuli, tumor necrosis factor-t~ (TNF) has 
been most intensively studied (15,  18, 22). 
It remains unclear how TNF elicits pleiotropic responses 
via receptors that embody no known enzymatic function (29, 
35). Tyrosine phosphorylation was recently recognized as a 
signal induced by TNF (1, 8, 37). The only distance in which 
TNF-induced tyrosine phosphorylation has been shown to 
be critical for function is in/32 integrin-dependent responses 
of TNF-treated PMN, namely, reorganization of their actin 
cytoskeleton and  secretion  of large  amounts  of hydrogen 
peroxide  (8).  Neither  the  tyrosine kinases  nor  their  sub- 
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strates involved in these responses have been characterized, 
beyond the localization of the most abundant tyrosine phos- 
phoproteins to the region of the cells close to or in contract 
with  the  substrate  (8).  Indeed,  only three  tyrosine phos- 
phoproteins have been identified in PMN treated with any 
stimulus:  microtubule-associated protein-2 kinase or mito- 
gen activated protein kinase (MAP kinase) (11), rel (6), and 
recently the tyrosine kinase p58~r (3).  Likewise, only two 
tyrosine phosphoproteins  have been identified  in  any cell 
treated with TNF:  MAP kinase (34) and p58  fgr (3). 
Here we study two leading  candidates  within  focal ad- 
hesions for tyrosine kinase substrates involved in the adhe- 
sion-dependent, polypeptide-triggered secretory response of 
PMN. Paxillin is a 68-kD protein purified from chick em- 
bryo fibroblasts (31) which binds to vinculin (9,  31),  v-crk 
(4),  and the SH3 domain  of c-src  (36),  localizes  in focal 
adhesions (31, 32), and undergoes tyrosine phosphorylation 
during adhesion of fibroblasts (5), neuropeptide stimulation 
of 3T3 cells (39),  phagocytosis by macrophages  (12),  and 
embryonic development of chicken and rat (30). Focal adhe- 
sion kinase (p125 F^x) is a  125-kD tyrosine kinase and c-src 
substrate (28) that is phosphorylated on tyrosine in response 
to adhesion  of fibroblasts and may  in turn  phosphorylate 
paxillin (16). The present experiments identified both paxil- 
lin and p125  r^K in human  PMN.  Paxillin  but not p125 F^z 
underwent  tyrosine  phosphorylation  in  response  to  TNE 
phorbol  ester  (PMA),  formyl-methionyl-leucyl-phenylala- 
nine (fMLP) and opsonlzed bacteria,  but only in adherent 
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cytoskeleton. 
Materials and Methods 
PMN 
PMN were isolated from heparinized blood of normal human donors and 
from a child with profound leukocyte adhesion deficiency (LAD) whose 
PMN responses were previously described (21), using a one-step, modified 
Ficoll-Hypaque gradient (Neutrophil Isolation Medium, Cardinal Associ- 
ates, Santa Fe, NM) as described (22). Erythrocytes were lysed by hypo- 
tonic shock and  PMN  resuspended in  ice-cold Krebs-Ringer phosphate 
buffer with glucose (KRPG) (145 mM NaC1,  5.7 mM sodium phosphate, 
4.86 mM KCI, 0.54  mM CaCI2,  1.22 mM MgSO4,  5.5 mM glucose, pH 
7.35, mOsm 300-315). For adherent cells, PMN were plated at 4  ×  106/ml 
in 5 ml in 100-mm Primaria  TM dishes (Falcon Labware, Becton-Dickinson 
& Co., Oxnard, CA) precoated with 3 ml FBS (Hyclone Systems, Logan, 
UT)  prewarmed to  37°C.  After  15  min,  stimuli and/or inhibitors were 
added. Pure recombinant human TNF was a gift of Genentech, Inc. (South 
San  Francisco, CA).  PMA,  fMLP,  and  dihydrocytochalasin B  (DHCB) 
were from Sigma Chemical Co.  (St.  Louis,  MO).  A  clinical  isolate of 
Listeria monocytogenes  from New York Hospital was opsonized by incuba- 
tion in 20% normal human serum for 1 h on ice, washed in PBS, and stored 
at -70°C. At the indicated times, the dishes were placed on ice, the incuba- 
tion medium was aspirated, and the residual cells were lysed in 125/zl of 
solubilization buffer (10 mM Tris-HCl, pH 7.4,  1%  SDS,  1 mM sodium 
vanadate, 0.1 mM sodium molybdate, 1 mM sodium pyrophosphate, 1 mM 
NaE  1 mM phenylmethylsulfonyl fluoride, 5 mM diisopropyl fluorophos- 
phate, and 5/zg/ml each of pepstatin A, leupeptin, aprotinin, and chymosta- 
tin). The lysate was immediately boiled for 5 min and then stored at -80°C 
until  further analysis. For suspended cells, 1 ml of the same suspension of 
PMN was incubated in FBS-coated polypropylene tubes and agitated at 100 
cycles/min; this was necessary to prevent adhesion of the cells to the walls 
of the tube or to each other. At the indicated times, the tubes were cen- 
trifuged at 16000 g for 10 s at room temperature (RT) and the cell pellets 
lysed in solubilization buffer as described above.  Where indicated, PMN 
(50  ×  106/ml) were preincubated with 1 /~g/ml of the specified antibodies 
for 30 min at 4°C with end-over-end rotation and then plated on FBS coated 
plates  as  above.  Protein concentrations of lysates  were determined by 
the Bradford or modified Lowry methods (Bio-Rad Laboratories,  Rich- 
mond, CA). 
Antibodies 
Anti-phosphotyrosine mAb 5E2  (IgG2b)  was a  generous gift of B.  M. 
Fendly  (Genentech Inc.,  South  San  Francisco,  CA)  (7).  Anti-p125 FAK 
mAb antibody 2A7 (mouse IgGl against chicken p125 FAK) was a generous 
gift of T. Parsons (University of Virginia, Charlottesville, VA) (14). Anti- 
paxillin mAb 349 (mouse IgGi against chicken paxillin), rabbit polyclonal 
anti-phosphotyrosine  IgG and recombinant, HRP-conjugated anti-phospho- 
tyrosine mouse mAb (RC20) were purchased from Transduction Laborato- 
ries (Lexington, KY). Anti-CDl8 mAb IB4 (mouse IgG2a) and its F(ab)'2 
fragments were a generous gift of S. Wright (Rockefeller University, New 
York). Anti-CD16 (Fc receptor) mAb 3G8 (mouse IgGt) was a kind gift of 
J. Unkeless (Mt. Sinai Medical School, New York). Normal mouse IgG was 
purchased from Pierce (Rockford, IL).  Monoclonal anti-vinculin (hVIN- 
1-1gG0 antibody was from Sigma Chemical Co. 
Immunoprecipitation 
Cell lysates normalized for protein concentration were diluted to 0.1% SDS 
in modified RIPA buffer (10 mM Tris-HCl, pH 7.5, 1% Triton X-100, 0.5% 
Nonidet-P40,  150  mM NaCI,  1 mM sodium vanadate,  0.1  mM sodium 
molybdate, 1 mM sodium pyrophosphate, 1 mM NaF, 1 mM phenylmethyl- 
sulfonyl fluoride, and 5 #g/ml each of pepstatin A, leupeptin, aprotinin, and 
chymostatin). Diluted lysates were incubated with mAbs at 1/100 dilution, 
except polyclonal anti-phosphotyrosine and anti-paxillin which were used 
at 1/200 dilution, at 4°C overnight with protein G-Sepharose beads (Phar- 
macia  LKB,  Uppsala,  Sweden).  Precipitated  immune  complexes were 
washed three times in modified RIPA buffer. The pellets were resuspended 
in SDS sample buffer and heated at 100*C  for 10 min before analysis by 
SDS-PAGE. 
Immunoblotting 
Lysates separated by SDS-PAGE (17) were transferred eletrophoretically to 
nitrocellulose membranes (Schleicher & Schuell, Inc., Keene, NH). Where 
specified, non-reducing conditions were used so that IgG heavy chain would 
not lie close to the molecular mass region of paxillin since the secondary 
reagents used for western blot detect IgG heavy chain and interfere with 
paxillin detection.  The  membranes were incubated overnight at 4°C  in 
blocking buffer (20  mM Tris-HCl, pH 7.4,  137 mM NaCI, 0.1% Triton 
X-100,  10% FBS) and then for 4 h at RT with one of the following: mAb 
5E2 at 1.5 ~g/rnl; mAb 2A7, 1/100 dilution; anti-paxillin mAb, 1/1,000 dilu- 
tion; or mAb RC20,  1/2,000  dilution, all in blocking buffer.  Membranes 
were washed in the same buffer without serum, blocked again in 20 mM 
Tris-HCl, pH 7.4,  137 mM NaCI, 0.1% Tween 20,  10%  FBS for 30 min 
at RT,  and incubated at RT  for 45 rain with HRP-conjugated IgG sheep 
anti-mouse IgG when appropriate (Amersham Corp., Arlington Heights, 
IL) in the same buffer. After further washing in the same buffer without se- 
rum, immunoblots were developed using an enhanced chemiluminescence 
(ECL) kit (Amersham Corp.). Where indicated the immunoblot films were 
subjected to densitometric analysis by scanning on a  Mirror 800 trans- 
parency scanner (Mirror Technologies, Roseville, MN) and the resulting 
scan analyzed by computer with the NIH Image 1.52 software. 
lmmunohistochemistry 
PMN (106 cells/ml) were plated on FBS-coated 13-ram  diam glass cover- 
slips in 12-well plates containing prewarmed reaction mixture. After 15 min 
to allow the cells to contact the coverslips, TNF (250 ng/ml) was added or 
cells were left untreated. After incubation for the indicated times at 37°C 
in air,  the medium was gently aspirated and cells fixed with 1% parafor- 
maldehyde in cacodylate buffer, pH 7.4 (75 mM sodium cacodylate, 0.72 % 
sucrose), for 10 rain at RT. The supernatant was then replaced with 3.7% 
formaldehyde in PBS for 10 min at RT. Cells were then washed with PBS 
and permeabilized with 0.05%  Triton X-100 in PBS for 4 min at RT. Fixed 
cells were incubated with blocking buffer (PBS +  10% calf serum) for 1 h 
at RT and then for 1 h at 37°C with a  1/100 dilution rabbit anti-phospho- 
tyrosine antibody and  1/100 dilution of mouse anti-vinculin in blocking 
buffer.  Coverslips were then washed three times in PBS and incubated for 
45  min at 37°C with rhodamine-conjugated goat IgG F(ab32 anti-rabbit 
IgG (3' and light chain) and fluorescein-conjugated goat IgG F(ab')2 anti- 
mouse IgG (3' and light chain) antibodies (Tago Laboratories, Burlingarne, 
CA) in blocking buffer.  Coverslips were washed twice in PBS and once 
in distilled water,  inverted, and mounted in 90%  glycerol in water on a 
glass slide. 
Results 
Phosphotyrosine-containing Proteins Colocalize 
with Vinculin 
Double staining  established that the majority  of immuno- 
reactive phosphoprotein was not only confined near the ad- 
herent  surface of PMN plated on FBS-coated glass (8) but 
was specifically localized in focal adhesions, as judged by its 
colocalization with vinculin in finger-like structures (Fig. 1). 
Identification of  Paxillin and p125  FAx in Human PMN 
and Assessment of Their ~rosine Phosphorylation in 
Response to TNF 
By immunoblot with anti-phosphotyrosine, the most readily 
detectable  proteins  to  undergo  tyrosine  phosphorylation 
in adherent,  TNF-treated  PMN  have  apparent  Mr ranging 
from 65,000 to 150,000 (8), spanning the sizes of focal adhe- 
sion proteins paxillin and p125 FAK. To determine if paxillin 
and p125 FAK are present in PMN  as tyrosine phosphopro- 
teins, PMN adherent to FBS-coated plates or in suspension 
were stimulated  with TNF for 60 min and their lysates im- 
munoprecipitated with anti-paxillin and anti-p125 FAK mAbs. 
Irnmunoprecipitates  were divided in two equal portions and 
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paxillin  or anti-p125 FAK mAbs.  Paxillin  was  detected  as  a 
broad band of apparent molecular mass ~70 kD in a reduc- 
ing SDS-PAGE immunoblot,  as  in other cells  and  species 
(5).  Paxillin  underwent  tyrosine  phosphorylation  only  in 
PMN that were both stimulated with TNF and allowed to ad- 
here (Fig. 2 A). As little as l0 ng/ml TNF was effective (not 
shown).  In contrast,  while  p125  ~AK was  detected  in  PMN 
and found to be tyrosine phosphorylated, its level of tyrosine 
phosphorylation was unaffected by adherence and/or  TNF 
(Fig.  2  B).  Blots  probed  with  anti-paxillin  mAb or  anti- 
p125  FAK mAb showed that the same amounts of the test pro- 
teins were immunoprecipitated  in each sample whether or 
not the cells  were adherent or stimulated  (not shown). 
Figure 1. Colocalization of phos- 
photyrosine-containing  proteins 
with vinculin.  PMN were plated 
on  FBS-coated  glass  coverslips 
and  15  min  later  treated  with 
TNF  (250  ng/ml).  After  45 
min  the  medium  (KRPG)  was 
aspirated  and  cells  fixed,  per- 
meabilized,  and  stained  with 
mouse  anti-vinculin  and  rabbit 
anti-phosphotyrosine antibodies. 
Secondary  antibodies  were  (,4) 
fluorescein-conjugated sheep anti- 
mouse,  reporting  vinculin,  and 
(B) rhodamine-conjugated sheep 
anti-rabbit,  reporting  phospho- 
tyrosine. Bar,  10/~M. 
Role of lntegrins 
PMN  from a  patient  with profound/~2  integrin deficiency 
failed to tyrosine phosphorylate paxillin in response to TNF 
(Fig.  3).  In normal  PMN,  paxillin  phosphorylation in re- 
sponse to TNF  was completely abolished  by pretreatment 
with  anti-CD18  mAb,  both  intact  and  as  the  F(at¢)2  frag- 
ment.  Normal  mouse IgG and  a  mAb binding  to another 
abundant  surface molecule (FcR) had no effect (Fig.  4). 
Kinetics of TNF-induced, Adhesion-dependent 
I)~osine Phosphorylation of  PaxiUin 
Tyrosine phosphorylation of paxillin  was first detected  15 
min after stimulation of adherent PMN with TNF, peaked at 
30 min and lasted at least 60 min. Again, tyrosine phosphor- 
ylation was dependent on adhesion to the serum-coated sur- 
face (Fig.  5).  A  blot of aliquots  of the  same  immunopre- 
Figure 2. Effect of TNF and cell adherence on tyrosine phosphory- 
lation of paxillin.  PMN were plated  on FBS-coated dishes  (lanes 
marked A) or kept in suspension in FBS-coated tubes (lanes marked 
S) and stimulated  with TNF (250 ng/ml)  or left untreated  for 60 
min.  Cell  lysates  (25  ttg)  were  immunoprecipitated  with  anti- 
paxillin mAb and separated by reducing SDS-PAGE, transferred  to 
a nitrocellulose  membrane and probed with anti-phosphotyrosine 
mAb followed  by ECL detection,  using  HRP-conjugated  sheep 
anti-mouse IgG antibody. (B) Effect of TNF stimulation on tyrosine 
phosphorylation  of p125  ~  in adherent and suspended PMN. PMN 
were prepared as in A. Cell lysates  (25/zg) were immunoprecipi- 
tated with anti-p125 r~K mAb, separated  by reducing SDS-PAGE, 
transferred  to nitrocellulose  and probed with anti-phosphotyrosine 
mAb,  followed  by ECL detection  using  HRP-conjugated  sheep 
anti-mouse IgG antibody. The expected migrations of paxillin  and 
p125  FAK are indicated,  along with molecular mass markers in kD. 
IgG heavy chain from the immunoprecipitating antibodies was also 
detected by the HRP-conjugated sheep anti-mouse IgG secondary 
antibody. 
Figure 3. Lack of paxillin phosphorylation in PMN from a patient 
with LAD. PMN were isolated  form a normal donor, a child with 
LAD, and  the patient's  unaffected  mother.  PMN were plated  on 
FBS-coated plates and stimulated with TNF (250 ng/ml) or left un- 
treated for 60 min. Cell lysates (80/zg except Cofthe LAD patient, 
20/~g) were immunoprecipitated  with anti-paxillin  mAb. Proteins 
were separated by nonreducing SDS-PAGE, transferred  to nitrocel- 
lulose,  and  probed  with  HRP-conjugated  anti-phosphotyrosine 
mAb followed by ECL detection.  Molecular mass marker is indi- 
cated in kD. 
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ies. PMN were isolated and incubated at 4°C for 30 min with intact 
anti-CDl8 mAb IB4 or its F(ab% fragments,  or as controls, nor- 
mai mouse IgG or mAb 3G8 directed  against  Fc receptor.  PMN 
were plated  on FBS-coated plates  and stimulated  with  TNF (250 
ng/ml) or left untreated  for 60 min.  Cell lysates (125/zg)  were im- 
munoprecipitated  with anti-paxillin  mAb. Proteins were separated 
by  nonreducing  SDS-PAGE,  transferred  to  nitrocellulose,  and 
probed with HRP-conjugated  anti-phosphotyrosine  mAb followed 
by ECL detection.  Molecular mass markers are indicated  in kD. 
cipitates probed with anti-paxillin  confirmed that the same 
amounts  of  paxillin  were  precipitated  in  all  cases  (not 
shown). In experiments with different PMN donors, the time 
of initial phosphorylation of  paxillin varied from 15-45 min, 
but always appeared to coincide with the onset of spreading 
of the PMN on the FBS-coated plates. 
Estimation of the Fraction of Paxillin Undergoing 
1~rosine Phosphorylation 
PMN on FBS-coated plates were stimulated with TNF for 
30 or 60 min or left untreated  for the same times.  Lysates 
14 
~  t2 
~  to 
-~  8  osine phosphorylated 
=L'  /  paxillin after 60 min of TNF 
I~  4-  Tyrosine phosphorylated 
2-  ~~~'-  paxillin after 30 min of TNF 
10  100 
% of total 
cellular paxillin 
Figure 6. Proportion of paxillin  undergoing  tyrosine phosphoryla- 
tion.  (A) PMN were plated  on FBS-coated dishes  and stimulated 
with TNF (T) (250 ng/ml) or left untreated (control, C) for the indi- 
cated times.  Cell lysates  (350/~g)  were immunoprecipitated  with 
anti-phosphotyrosine  polyclonal Ab. The supernatants  were immu- 
noprecipitated  again with anti-paxillin  mAb. Different amounts (as 
indicated) of the total immunoprecipitated  paxillin  were loaded in 
each lane. The samples were subjected to nonreducing SDS-PAGE 
and the separated  proteins transferred  to nitrocellulose  and probed 
with  anti-paxillin  followed  by  ECL detection.  Molecular  mass 
marker is indicated  in kD. (B). The bands present  in the immuno- 
blot from  A were subjected to densitometry and the density (relative 
units) plotted against the fraction of total immunoprecipitated  pax- 
illin  loaded  in each lane.  The regression  function  (r  2 =  0.993) 
from the anti-paxillin  immunoprecipitates  (e) was used to calculate 
the  amount  of paxillin  present  in the  anti-phosphotyrosine  im- 
munoprecipitates  (,). 
Figure 5. Time course of TNF-stimulated  tyrosine phosphorylation 
of paxillin.  PMN were plated on FBS-coated plates  (A) or kept in 
suspension  (S) and stimulated  with TNF (250 ng/ml)  or left un- 
treated for the indicated times. Cell lysates (300 t~g) were immuno- 
precipitated  with anti-paxillin  mAb.  Proteins  were separated  by 
nonreducing SDS-PAGE, transferred  to nitrocellulose  and probed 
with HRP-conjugated  anti-phosphotyrosine  mAb followed by ECL 
detection.  Molecular mass marker is indicated  in kD. 
were immunoprecipitated with polyclonal anti-phosphotyro- 
sine to  separate  paxillin  that was tyrosine-phosphorylated 
from paxillin that was not. The supernatants from these sam- 
ples were immunoprecipitated again using anti-paxillin mAb 
to collect the remaining paxillin.  Both immunoprecipitates 
were divided in different proportions (see Fig. 6 A legend) 
and immunoblotted with anti-paxillin  or anti-phosphotyro- 
sine. Paxillin was present in the antiphosphotyrosine immu- 
noprecipitates  after 30 min of TNF treatment and in even 
greater amount after 60 rain. Very little paxillin was present 
in anti-phosphotyrosine immunoprecipitates of  control cells. 
However, the majority of total cellular paxillin was present 
in the supernatants of the anti-phosphotyrosine immunopre- 
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B)  showed that the immunoblot ECL reaction was  linear 
with respect to the logarithm of cell protein in the range of 
interest (2-20 % of total non-tyrosine phosphorylated cellu- 
lar paxillin).  The regression function from the anti-paxil- 
lin immunoprecipitates was used to calculate the amount of 
paxillin present in the anti-phosphotyrosine immunoprecipi- 
tates. By this analysis, 2 % of total cellular paxillin was tyro- 
sine phosphorylated after 30 min and 4.5%  was  tyrosine 
phosphorylated after 1 h of treatment of adherent PMN with 
TNE The efficacy of anti-phosphotyrosine and anti-paxillin 
immunoprecipitation was confirmed by the absence of tyro- 
sine-phosphorylated paxillin in the paxillin immunoprecipi- 
tates and by the absence of tyrosine phosphorylated proteins 
and paxillin in the final supernatants  (not shown). 
PaxiUin Undergoes a Posttranslational Modification 
Different from l~rosine Phosphorylation 
In  the  same  experiments  paxillin  immunoprecipitates 
depleted of tyrosine-phosphorylated  paxillin from control or 
TNF-stimulated cells were also analyzed. Immunoblots with 
anti-paxillin  (Fig.  7)  showed that the  apparent molecular 
weight of  the non-tyrosine phosphorylated paxillin increased 
from 51 kD (on nonreducing SDS-PAGE) in untreated cells 
to 58 kD in TNF-stimulated cells after 30 rain, and to 63 kD 
after 60 min of stimulation.  This demonstrated the occur- 
rence of a  time-dependent, TNF-induced posttranslational 
modification(s)  of paxillin  different  from  tyrosine  phos- 
phorylation. 
Role of the Actin-based Cytoskeleton 
Dihydrocytochalasin B blocks the barbed end of actin fila- 
ments and inhibits both spreading and the respiratory burst 
in  TNF-stimulated  PMN  (18, 22).  Accordingly, adherent 
PMN were stimulated with TNF in the presence or absence 
of DHCB or left untreated for different lengths of time. Cells 
were lysed and samples immunoprecipitated with anti-paxil- 
lin  mAb.  Equal  aliquots  of the  immunoprecipitates  were 
blotted  with  anti-paxillin  or  anti-phosphotyrosine  mAbs. 
DHCB blocked completely the tyrosine phosphorylation of 
paxillin after 45 min of TNF stimulation. After 60 rain only 
a very small amount of tyrosine phosphorylation was pres- 
ent, a marked reduction compared to cells treated with TNF 
but not with DHCB. Immunoblot of the same samples with 
Figure 7. Paxillin undergoes a 
posttranslational modification 
different from tyrosine phos- 
phorylation. PMN were plated 
on  FBS-coated  dishes and 
stimulated with TNF (T) (250 
ng/ml) or left untreated (con- 
trol, C) for the indicated times. 
Cell  lysates  (350  /zg) were 
immunoprecipitated with anti- 
phosphotyrosine polyclonal Ab. The supernatants were immuno- 
precipitated again with anti-paxillin mAb. The phosphotyrosine- 
immunodepleted anti-paxillin immunoprecipitates were subjected 
to nonreducing SDS-PAGE and the separated proteins transferred 
to nitrocellulose and probed with anti-paxillin followed  by ECL de- 
tection. Molecular mass marker is indicated in kD. 
Figure 8. Effect of DHCB on tyrosine phosphorylation of paxillin. 
PMN were plated on FBS-coated dishes and stimulated with TNF 
(250 ng/ml) in the presence or absence of DHCB (10 ttg/ml) or left 
untreated for the indicated times. Cell lysates (150 #g) were immu- 
noprecipitated with anti-paxillin mAb, separated by nonreducing 
SDS-PAGE, transferred to nitrocellulose, and probed with HRP- 
conjugated anti-phosphotyorsine mAb or anti-paxillin mAb fol- 
lowed by ECL detection. Molecular mass markers are indicated 
in kD. 
anti-paxillin showed that similar amounts were immunopre- 
cipitated in all cases (Fig.  8). 
Response to Other Stimuli 
Phorbol ester, a potent activator of protein kinase C, formyl- 
methionyl-leucyl-phenylalanine, a  chemotactic peptide re- 
leased  from Escherichia  coli,  and  serum-coated Listeria 
monocytogenes  all caused PMN to tyrosine phosphorylate 
paxillin. Although PMA stimulated less tyrosine phosphory- 
lation of paxillin than TNE PMA caused a greater upshift 
in paxillin's apparent molecular mass (Fig. 9). 
Discussion 
Tyrosine phosphorylation is essential for human PMN ad- 
herent  to  model  biological  surfaces  to  reorganize  their 
cytoskeleton and undergo a large-scale respiratory burst (8). 
This work demonstrates that most tyrosine phosphoproteins 
in  TNF-stimulated PMN  are confined to focal adhesions, 
that the focal adhesion protein paxillin is present in human 
PMN, and that the tyrosine phosphorylation of paxillin is in- 
duced by a cytokine and microbial products, provided that 
the cells can adhere, utilize/32 integrins, and reorganize ac- 
Figure  9.  Effect of different 
stimuli on tyrosine phosphor- 
ylation of paxiUin. PMN were 
plated  on FBS-coated plates 
(A) and stimulated with TNF 
(/~, 250 ng/ml), PMA (P; 100 
ng/ml), fMLP (F; 1 #M), op- 
sonized bacteria (L; 6  x  10~/ 
ml), or left untreated (C) for 
60 min. Cell lysates (125 #g) 
were immunoprecipitated with anti-paxillin mAb. Proteins were 
separated by nonreducing SDS-PAGE, transferred to nitrocellu- 
lose, and probed with HRP-conjugated anti-phosphotyrosine mAb 
followed by ECL detection. Molecular mass markers are indicated 
in kD. 
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to  undergo  tyrosine phosphorylation  in  response  to  any 
agonist in PMN or in response to TNF in any cell. 
These studies also identify p125 ~AK in human PMN. Due 
to the common localization of p125 FAK and paxillin in focal 
adhesions (28, 31), their concomitant phosphorylation (5, 
25,  39),  and the ability of immunoprecipitated p125  FAK to 
tyrosine phosphorylate purified paxillin in vitro (33),  it has 
been suggested that tyrosine phosphorylation of paxillin may 
result from the activation of p125  FAK (39).  However,  in the 
present work, p125 FAK did not change its tyrosine phosphor- 
ylation state in  response  to  stimulation with TNE  Since 
tyrosine phosphorylation of p125  ~AK is generally considered 
one means of activation, this finding directs attention to the 
probable existence in neutrophils of a non-p125 FAK pathway 
for integrin- and cytokine-dependent tyrosine phosphoryla- 
tion of a focal adhesion-associated protein. Consistent with 
this, Greenberg et al. (12) observed tyrosine phosphoryla- 
tion of paxillin after Fc-receptor mediated phagocytosis by 
macrophages in the absence of p125 FAr tyrosine phosphory- 
lation. They suggested that p72 Syk, a tyrosine kinase present 
also in PMN (2), might be responsible. Similarly, Huang et 
al. (13) observed tyrosine phosphorylation of a protein of 68 
kD in platelets whose integrins were ligated under conditions 
that did not stimulate tyrosine phosphorylation of p125 FAK. 
Alternatively, it is possible in our studies that constitutively 
active p125  ~AK did phosphorylate paxillin,  but  only after 
TNF  acted  to  bring  the  two  proteins  together,  or  that 
p125 ~AK was activated by a mechanism other than tyrosine 
phosphorylation. Recently, Berton et al.  (3)  reported that 
the  tyrosine  kinase  p58rgr is  activated  in  a  f12  integrin- 
dependent manner in adherent neutrophils, and that its phos- 
phorylation and activation are enhanced by TNE  making 
p58rgr another candidate to tyrosine phosphorylate paxillin. 
Tyrosine kinase substrates in PMN treated with inflamma- 
tory polypeptides fall into three classes.  Those which are 
rapidly phosphorylated and dephosphorylated may partici- 
pate in early stages of signal transduction. The only member 
of this class identified to date has been MAP kinase (11). 
Tyrosine phosphorylation of the second class of substrates 
(ppl50,  ppll5, pp75, pp65) is slow in onset and prolonged in 
duration (8). These appear likely to be involved in the reor- 
ganization of the cytoskeleton in adherent PMN, in that: (a) 
they colocalize with vinculin in focal adhesions (Fig. 1); (b) 
inhibition of their phosphorylation aborts cell spreading (8); 
(c) the kinetics of their phosphorylation matches that of cell 
spreading (8, 23, 24); and (d) an intact cytoskeleton protects 
them from premature dephosphorylation (8).  On the other 
hand,  as monitored by anti-phosphotyrosine immunoblot, 
most of the slowly phosphorylated proteins do not require 
actin polymerization to undergo tyrosine phosphorylation 
(8). Paxillin falls into a third class in TNF-treated PMN, not 
previously described, in that actin polymerization was essen- 
tial for its tyrosine phosphorylation to reach a  detectable 
level.  Similarly,  cytochalasin D  blocked  bombesin-  and 
PDGF-stimulated tyrosine phosphorylation of paxillin (and 
p125 FAK) in Swiss 3T3 cells (25, 38, 39).  In the latter cells, 
PDGF stimulated paxillin tyrosine phosphorylation up to a 
concentration of PDGF at which it began to cause actin 
cytoskeleton disassembly. At higher concentrations, PDGF 
was no longer effective (25).  Therefore it appears  that in 
PMN as in 3T3 cells, an intact cytoskeleton is necessary ei- 
ther to permit activation of the tyrosine kinase responsible 
for paxillin phosphorylation or to bring paxillin and the ki- 
nase into apposition. In phagocytizing macrophages, on the 
other hand, cytochalasin D did not affect paxillin phosphory- 
lation confined to the phagocytic cup (12). 
Paxillin tyrosine phosphorylation was undetectable in a 
PMN from a patient with LAD. These cells lacked expres- 
sion of all three leukocyte integrins-CD1 la/CD18 (LFA-1), 
CDllb/CD18  (Mac-l, CR3), and CDllc/CD18 (p150,95)- 
that share the f12 chain (CD18).  The same phenotype was 
conferred on normal PMN by incubation with mAb anti- 
CD18. The availability of these integrins is a requirement for 
several  TNF-induced PMN responses, including hydrogen 
peroxide production (24),  changes in  intracellular cAMP 
(21),  degranulation (26),  and activation of unidentified ki- 
nase(s)  (8). 
A posttranslational modification(s) also occurred in TNF- 
treated PMN involving those paxillin molecules which es- 
caped  tyrosine phosphorylation.  Preliminary experiments 
(Fuortes, M., manuscript in preparation) indicate that this 
represented phosphorylation on serine. Different phosphor- 
ylation states of paxillin may regulate its association with 
different subsets of proteins. 
The role of paxillin in any cell remains to be established. 
The present work suggests that tyrosine phosphorylation of 
paxillin by a kinase which is probably distinct from p125  FAK 
may help regulate the dramatic changes in cell shape and 
secretory behavior with which PMN respond to a  major 
inflammatory mediator,  TNF,  and to  microbes  and their 
products.  Paxillin is well positioned to play a  key role in 
these processes, given its its localization in focal adhesions 
and its ability to interact with tyrosine kinases like p125 FAK 
(31), src (10), Csk (27), and lyn (19), "adaptor" proteins like 
crk (4), and structural proteins like vinculin (31). Indeed, 
paxillin now appears to be a point of convergence within fo- 
cal  adhesions for the  actions of cytokines and microbial 
products (this study), neuropeptides (39),  oncogenes (20), 
and integrins (5). 
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